Intellectual Property India Publishes Patent Application for Compositions And Methods Comprising Small Nuclear Rna (snrna) Targeting Sod1

MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617084456 A) filed by Regeneron Pharmaceuticals, Inc. on July 09, 2026, for Compositions And Methods Comprising Small Nuclear Rna (snrna) Targeting Sod1.

Inventors include Roth, Daniela; and Bradford, William Henry.

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: SnRNA systems targeting SOD1 RNA sequences are disclosed herein. Further disclosed are methods of treating Amyotrophic Lateral Sclerosis.

Disclaimer: Curated by HT Syndication.